Dermapharm Holding SE
DUS:DMP
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
D
|
Dermapharm Holding SE
DUS:DMP
|
DE |
|
A
|
Aurizon Holdings Ltd
F:QRL
|
AU |
|
Greggs PLC
LSE:GRG
|
UK |
|
P
|
Pure Hydrogen Corporation Ltd
ASX:PH2
|
US |
|
T
|
Torpol SA
WSE:TOR
|
PL |
|
Excel Industries Ltd
NSE:EXCELINDUS
|
IN |
|
F
|
First Gen Corp
XPHS:FGEN
|
PH |
|
Turkcell Iletisim Hizmetleri AS
NYSE:TKC
|
TR |
|
Cordlife Group Ltd
SGX:P8A
|
SG |
|
I
|
Infraset PCL
SET:INSET
|
TH |
|
Anexo Group PLC
LSE:ANX
|
UK |
|
Maxlinear Inc
NASDAQ:MXL
|
US |
|
Aisix Solutions Inc
XTSX:AISX
|
CA |
|
R
|
Rashi Peripherals Ltd
NSE:RPTECH
|
IN |
Wall Street
Price Targets
DMP Price Targets Summary
Dermapharm Holding SE
According to Wall Street analysts, the average 1-year price target for
DMP
is 42.91 EUR
with a low forecast of 34.07 EUR and a high forecast of 50.01 EUR.
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is DMP's stock price target?
Price Target
42.91
EUR
According to Wall Street analysts, the average 1-year price target for
DMP
is 42.91 EUR
with a low forecast of 34.07 EUR and a high forecast of 50.01 EUR.
What is Dermapharm Holding SE's Revenue forecast?
Projected CAGR
3%
For the last 9 years the
compound annual growth rate for
Dermapharm Holding SE's revenue is
13%.
The projected
CAGR
for the next 4 years is
3%.
What is Dermapharm Holding SE's Operating Income forecast?
Projected CAGR
7%
For the last 9 years the
compound annual growth rate for
Dermapharm Holding SE's operating income is
14%.
The projected
CAGR
for the next 4 years is
7%.
What is Dermapharm Holding SE's Net Income forecast?
Projected CAGR
14%
For the last 9 years the
compound annual growth rate for
Dermapharm Holding SE's net income is
28%.
The projected
CAGR
for the next 4 years is
14%.
